Sommaire

Numéro précédent

• • ·Editorial board

    Page :A3

    
• • ·Table of contents

    Page :A5

    
• • ·Information for readers

    Page :A28

    
• • ·JAAD Case Reports article list

    Page :A31

    
• • ·Journal based CME instructions and information

    Page :A36

    

• Continuing Medical Education

  • ·Augmented intelligence and dermatology—Part I: Core concepts and applications

    Page :1-8

    Daniel Schlessinger, Justin Ko, Ivy Lee, Veronica Rotemberg, Roberto Novoa

    Résumé Résumé Plan Plan  
  • ·CME examination

    Page :9

    
  • ·Answers to CME examination

    Page :10

    
  • ·Augmented intelligence and dermatology—Part II: Bias, benchmarks, guidelines, ethics, regulation, and future directions

    Page :11-19

    Edwin Dovigi, Shannon Wongvibulsin, Ivy Lee, Rob Novoa, Zhuo Cai, Veronica Rotemberg, Roxana Daneshjou

    Résumé Résumé Plan Plan
  • ·CME examination

    Page :20-21

    
  • ·Answers to CME examination

    Page :22

    

• Letter from the Editor

  • ·Letter from the editor: Timolol for wound healing

    Page :23-24

    Dirk M. Elston

    

• This Month in JAAD

  • ·This month in JAAD: January 2026

    Page :25

    Dirk M. Elston

    

• Highlights from JAAD Case Reports

  • ·Highlights from JAAD Case Reports: January 2026

    Page :26

    Abby Susan Van Voorhees

    

• Highlights from JAAD International

  • ·Highlights from JAAD International: January 2026

    Page :27

    Jonathan Kantor

    

• Highlights from JAAD Reviews

  • ·Highlights from JAAD Reviews: January 2026—The changing treatment landscape of alopecia areata

    Page :28-29

    Shari R. Lipner

    

• A Clinician's Perspective

  • ·Multidrug-resistant Candida auris: My mother’s prescience

    Page :30-31

    Warren R. Heymann

    

• Original Articles

  • ·Efficacy and safety of ruxolitinib cream for the treatment of moderate to severe chronic hand eczema: Results from a 16-week, multicenter, randomized, double-blind study

    Page :32-40

    Matthew Zirwas, Joseph F. Fowler, Athanasios Tsianakas, Alim R. Devani, Philippa Halden, Zhihong Lai, YuTzu Kuo, Haq Nawaz, Linda F. Stein Gold

    Résumé Résumé Plan Plan  
  • ·Effectiveness of biologics on synovitis and enthesitis using musculoskeletal ultrasound assessment in subclinical psoriatic arthritis: A 12-week observational real-world study

    Page :41-47

    Zhao Liu, Jiawen Chen, Kunli Zhou, Ting Gong, Rongying Chen, Zhixun Xiao, Hui Ke, Cuirong Xiao, Jianping Lan, Chao Ji, Niu Xiang

    Résumé Résumé Plan Plan  
  • ·Efficacy and safety of cosibelimab in advanced cutaneous squamous cell carcinoma: Results from a Pivotal Open-label Study with a median follow-up of ≥2 years

    Page :48-56

    Emily S. Ruiz, Eva Muñoz-Couselo, Henri Montaudié, Miguel Angel Berciano-Guerrero, Maria del Carmen Álamo de la Gala, Julie Charles, Gaëlle Quéreux, Charlée Nardin, Ricardo Yaya Tur, Stéphane Dalle, Marie Beylot-Barry, Rahul Ladwa, Margaret McGrath, Daniel Brungs, Dean Harris, Hong Shue, Andrea Tazbirkova, Samuel Fourie, Daniel R. Malan, James Oliviero, Lauren Neighbours Wilcoxen, W. Garrett Gray, Philip Clingan

    Résumé Résumé Plan Plan  
  • ·Highly selective, allosteric inhibition of TYK2 with oral ESK-001 in patients with moderate-to-severe plaque psoriasis: Results from STRIDE, a 12-week, randomized, double-blinded, placebo-controlled, dose-ranging phase 2 study

    Page :57-65

    Andrew Blauvelt, Petr Arenberger, Maxwell B. Sauder, Megan Couvillion, Roman G. Rubio, Nicholas E. Vlahakis, Sibel Ucpinar, Grace Ma, Elena Hitraya, Mera K. Tilley, Kim A. Papp, STRIDE Investigators

    Résumé Résumé Plan Plan  
  • ·Proteomic profiling reveals distinct inflammatory and neurogenic endotypes in rosacea

    Page :66-72

    Jundong Huang, Yifan Zhang, Caitan Yi, Xin Xiao, Dan Jian, Wei Shi, Fangfen Liu, Yingxue Huang, Zhixiang Zhao, Yan Tang, Mengting Chen, Zhili Deng, Ji Li, Yiya Zhang, Ben Wang

    Résumé Résumé Plan Plan  
  • ·Caged-hypocrellin-mediated antimicrobial photodynamic therapy as a dual-action strategy for fungal clearance and immune response regulation in drug-resistant Candida auris wound infections

    Page :73-80

    Xinyao Liu, Shaohua Guo, Jiao Wang, Linwan Zhang, Yusong Lin, Yuzhou Liu, Jiangshan Ouyang, Dongmei Shi, Bin Xu, Wenjie Fang, Yuping Ran

    Résumé Résumé Plan Plan  
  • ·Chronic skin diseases and life trajectories: Development and validation of “Dermatology Long-Term Life Impact Measure”

    Page :81-87

    Jonathan I. Silverberg, Charbel Skayem, Ann'Laure Demessant Flavigny, Caroline Le Floc'h, Stéphanie Merhand, Wendy Smith Begolka, África Luca de Tena Smith, Shulamit Burstein, Claire Della Vedova, Emmanuel Chamorey, Delphine Kerob, Charles Taieb, Khaled Ezzedine

    Résumé Résumé Plan Plan  
  • ·Effect of prenatal high-dose vitamin D on childhood atopic dermatitis is modified by maternal cotinine metabolome: A secondary analysis of a randomized clinical trial

    Page :88-95

    Nicklas Brustad, Tingting Wang, Liang Chen, Hannah Kaiser, Beatriz Gomes, Amalie Klein, Nilo Vahman, Lone Skov, Jakob Stokholm, Ann-Marie Schoos, Klaus Bønnelykke, Bo Chawes

    Résumé Résumé Plan Plan  
  • ·Disparities in survival and tumor characteristics in patients with single and multiple primary Merkel cell carcinomas

    Page :96-103

    Zehao Luo, Yuming Sun, Ziyu Guo, Jiayuan Le, Shiyu Zhang, Yao Yu, Shengchao Xu, Furong Zeng, Guangtong Deng

    Résumé Résumé Plan Plan  
  • ·Real-world treatment patterns in patients with generalized pustular psoriasis: A US-based claims study

    Page :104-112

    Bruce Strober, Hannah Kwiatkowski, Layla Lavasani, Juan Semeco, Bhargav Lakshminarasimhan, Mark Lebwohl, Alice B. Gottlieb

    Résumé Résumé Plan Plan  
  • ·Intralesional acyclovir versus cryotherapy in treatment of plantar warts: A randomized controlled trial

    Page :113-119

    Yousra Azzazi, Basant Helal, Shahira Ramadan

    Résumé Résumé Plan Plan  
  • ·Reflectance confocal microscopy reduces biopsies in adults and children: A prospective real-life study

    Page :120-127

    Sebastián González-Valdés, Sergio Bustos, Francisca Donoso, Marie-Chantal Caussade, Andrea Antunez-Lay, Katherine Droppelmann, Pablo Uribe, Giovanni Pellacani, Alvaro Abarzúa-Araya, Cristian Navarrete-Dechent

    Résumé Résumé Plan Plan  
  • ·Prevalence, incidence, and risk factors for dermatologic conditions in people with HIV in the modern antiretroviral era: A cohort study in Washington, DC

    Page :128-142

    Yagiz Matthew Akiska, Morgan Byrne, Mana Nasseri, Adeline Koay, Michael A. Horberg, Anne Monroe, Adam Friedman, Natella Rakhmanina, the DC Cohort Executive Committee

    Résumé Résumé Plan Plan  
  • ·Novel TYK2 inhibitor D-2570 in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase 2 trial

    Page :143-150

    Jianzhong Zhang, Cheng Zhou, Guoying Miao, Shoumin Zhang, Xinsuo Duan, Liming Wu, Guoqiang Zhang, Ningning Dang, Yangfeng Ding, Hongfang Han, Aihua Wei, Bin Yang, Linfeng Li, Shanshan Li, Xunyi Dai, Jianglin Zhang, Tiechi Lei, Wenjie Yan, Lixia Zhang, Zudong Meng, Rixin Chen, Qiuhe Song, Liangchun Wang, Wenhui Wang, Xinglin Hu, Ziyong Xiang, Zhe Shi, Ling Zhang

    Résumé Résumé Plan Plan  
  • ·Impact of immunosuppression on cutaneous squamous cell carcinoma outcomes

    Page :151-160

    Jason C. Klein, Kathryn T. Shahwan, Ursa Bezan Petric, Teja Mallela, Lindsey Voller, Emily Ruiz, Nina Ran, Emily E. Granger, Shlomo Koyfman, Allison Vidimos, Ashley Wysong, Kelsey Hirotsu, John A. Carucci, Joi B. Carter, Javier Cañueto, Fabio Muradás Girardi, Aaron R. Mangold, David G. Brodland, John A. Zitelli, Tyler J. Willenbrink, William Lotter, Vincent Jeanselme, Melica Nikahd, Rajiv I. Nijhawan, Divya Srivastava, David R. Carr

    Résumé Résumé Plan Plan  
  • ·Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial

    Page :161-171

    Cheng Zhou, Chunjun Yang, Weixin Fan, Jiyuan Wu, Dingquan Yang, Hongzhong Jin, Qinping Yang, Guohong Hu, Nengxing Lin, Xiumin Yang, Jianji Wan, Jianglin Zhang, Liming Wu, Yeqin Dai, Lili Ma, Shanshan Li, Juan Su, Jianfang Sun, Yangfeng Ding, Rong Xiao, Su Zhang, Wenwen Jiang, Lihao Wang, Jianzhong Zhang

    Résumé Résumé Plan Plan  
  • ·Real-world effectiveness and safety of oral Janus kinase inhibitor in vitiligo: A retrospective study

    Page :172-178

    Xiaoyi Shi, Yukun Yuan, Rongsi Sun, Mengyi Zhu, Juan Du, Fang Wang, Xiaolan Ding

    Résumé Résumé Plan Plan
  • ·Economic and environmental benefits of greening a Mohs surgery clinic: A comprehensive intervention and analysis

    Page :179-186

    Ireland Wayt, Rachel Cahn, William Farmer, Eric Bonar, Zachary Zinn, Vlad Codrea

    Résumé Résumé Plan Plan  
  • ·Safety and efficacy of envudeucitinib, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: Results from the 52-week open-label extension period of the phase 2 STRIDE study

    Page :187-195

    Kim A. Papp, Shahram Jacobs, Howard Sofen, Michael Bukhalo, Elisa Muscianisi, Grace Ma, Gabriel Lau, Michelle Bettinger, Roman G. Rubio, Elena Hitraya, Andrew Blauvelt, Open-Label Extension study team

    Résumé Résumé Plan Plan  

• From the Academy

  • ·Response to Chu et al’s “Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE− and Institute of Medicine−based recommendations”

    Page :196-199

    Melissa Shive, Elena Hawryluk, Aaron M. Drucker, Lindsy Frazer-Green

    Plan Plan

• Clinical Review

  • ·Low-dose naltrexone for treatment of dermatologic conditions: A clinical review

    Page :200-207

    Maggie H. Zhou, Dirk M. Elston, Brian W. Morrison, Shari R. Lipner

    Résumé Résumé Plan Plan  

• Brief Reports

  • ·Efficacy of 0.25% timolol gel in healing surgical open wounds: A randomized clinical trial

    Page :208-210

    Nancy Anabaraonye, Nina Ran, Emily E. Karn, Fadi Murad, David Stein, Emily Ruiz, Chrysalyne Schmults, Abigail Waldman

     
  • ·Inpatient management of hidradenitis suppurativa: A single-center retrospective study

    Page :210-212

    Narges Maskan Bermudez, Marita Yaghi, Scott A. Elman, Robert S. Kirsner, Hadar Lev-Tov

    
  • ·Topical estrogen for skin aging: A systematic review of safety and efficacy

    Page :212-215

    Eliana Farkas, Alexandra Goldblatt, Isabella Nehorayan, Rivka Bella Lefkowitz, Lauren Fleshner, Katharine Tepper, Shoshana Marmon

     
  • ·Use of oral minoxidil for androgenetic alopecia in transgender and gender-diverse people. A retrospective study of 27 patients

    Page :215-218

    Daniel Ramos-Rodríguez, Daniel Sanchez-Baez, Patricia Cabrera Garcia, Angela Hermosa-Gelbard, David Saceda-Corralo, Sergio Vaño-Galvan, Juan Jimenez-Cauhe

    Plan Plan  
  • ·Impact of presenter racial/ethnic concordance on sun protection education for low-income Latine high school students: A pilot study

    Page :218-220

    Nathaly Gonzalez, Olushola L. Akinshemoyin Vaughn

    Plan Plan
  • ·Cardiovascular safety of low-dose oral minoxidil in nonscarring alopecia: A multicenter population-based cohort study using TriNetX

    Page :220-223

    Christopher J. Thang, Jasmine Levine, Lillian Mo, Katie Roster, David Garate, Jordan Talia, Nicholas Gulati, Jonas Adalsteinsson, Benjamin Ungar

    
  • ·Association between DPP4 inhibitor use and risk of skin cancer in type 2 diabetes: A real-world cohort study

    Page :223-224

    Zaryab Alam, Kevin T. Nguyen, Hamza Malick, Kyle C. Lauck, Stanislav N. Tolkachjov

    
  • ·Impact of clinical factors and surgical treatments on sebaceous carcinoma patients with and without Muir-Torre syndrome

    Page :224-226

    Jalal Maghfour, Molly Powers, Anqi Wang, Laila Poisson, Shang I. Brian Jiang

    Plan Plan
  • ·Drug and vaccine-associated pemphigoid in patients aged 50 years and older: A pharmacovigilance study

    Page :226-229

    Tung S. Tran, Duc V. Le, Trang M. Nguyen, Julia S. Lehman, David A. Wetter, Giang H. Nguyen

    
  • ·Heterogeneous response to spesolimab in pyoderma gangrenosum depends on underlying myeloid disorders

    Page :229-231

    Youcong Wang, Yeping Ruan, Mengya Chen, Xiaoqing Zhao, Xia Li, Meng Pan, Jie Zheng, Lihong Chen

    
  • ·Primary cutaneous nocardiosis: A systematic review

    Page :232-233

    Ziwen Xu, Fangfang Bao, Hong Liu, Furen Zhang

    
  • ·A retrospective analysis of cutaneous metastasis in non-Hispanic Black and Hispanic patients

    Page :234-235

    Daniel S. Alicea, Shaun Wu, Jimmy Sanchez, Yasmine Oprea, Juan Lin, Dean Hosgood, Beth N. McLellan

     
  • ·Predictors of response to anifrolumab in cutaneous lupus erythematosus: A prospective cohort study of 57 patients

    Page :235-238

    Jeanne de La Rochefoucauld, Alexandre Teboul, Nassim Ait Abdallah, Gabrielle Sonigo, Matthias Papo, Caroline Charre, Baptiste Fouquet, Delphine Sterlin, Guy Gorochov, Alexis Mathian, Zahir Amoura, François Chasset

     
  • ·Prospective cohort study comparing hidradenitis suppurativa-associated atrophic scar treatments: Fractional carbon dioxide laser versus fractional radiofrequency microneedling

    Page :238-240

    G. Ege Eskibozkurt, Soahum Bagchi, Martina Porter, Sepideh Ashrafzadeh, Thao-Mary Tran, Hye Jin Chung

     
  • ·Public concerns versus consumer behavior: Sunscreen use increased despite benzene and reef-safety controversies (2009-2023)

    Page :241-242

    Charles B. Lau, Gideon P. Smith

    Plan Plan  
  • ·Trends and inequities in opioid prescriptions after Mohs surgery: Insights from the TriNetX network

    Page :242-245

    Stefano M. DiCenso, Bryan T. Carroll, Cerrene Giordano

    
  • ·The global burden of nonmelanoma skin cancers: A longitudinal analysis from the Global Burden of Disease Study, 1990˜2021

    Page :245-247

    Yulin Sun, Biao Song, Chengling Liu, Wenjing Cheng, Sijia Ni, Lingling Jia, Minjuan Wu, Hua Jiang

     
  • ·The impact of pulsed dye lasers on photodynamic therapy: Treatment schedules considerations for port-wine stains

    Page :247-250

    Jiawen Qin, Lan Luo, Yue Han, Lixin Zhang, Gang Ma, Xiaoxi Lin, Hanru Ying

     
  • ·Neutrophil-predominant inflammation is uncommonly seen in pyoderma gangrenosum: A retrospective review

    Page :250-252

    Jenna E. Koblinski, Sarah Gold, Marta Taye, Kalina T.L. Machado, Justin T. Cheeley

    
  • ·Safety of rituximab in Mohs micrographic and dermatologic surgery: A retrospective cohort study

    Page :253-254

    Katherine G. Thompson, Shanelle M. Briggs, Bradey A.R. Stuart, Melanie Clark, Daniel Knabel, Julia M. Kasprzak

    
  • ·Efficacy and safety of abrocitinib in elderly Chinese patients with moderate-to-severe atopic dermatitis: A single-center, retrospective study

    Page :254-256

    Xi Tan, Shu Nie, Zhouwei Wu

    
  • ·Risk factors for acne relapse and isotretinoin retreatment after initial treatment of acne vulgaris with high-dose isotretinoin: A retrospective cohort study

    Page :256-258

    Emily G. Summers, Nga Nguyen, Dean S. Morrell

    Plan Plan
  • ·Sitosterolemia-related necrobiotic xanthogranuloma

    Page :258-261

    Peng-Yu Chen, Jing Jing, Yuan-Yu Hong, Jue-Xing Li, Heng Zhang, Jia-Qi Chen, Zhuang-Li Tang, Sui-Qing Cai

    
  • ·Adverse events of topical treatments for rosacea: A systematic review of randomized controlled trials

    Page :261-264

    Jia Qi Adam Bai, Ryan S.Q. Geng, Edgar Akuffo-Addo, Megan Lam, Cathryn Sibbald

     
  • ·Germline pathogenic variants and immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors

    Page :264-267

    Alan Shen, Michelle Arbesman, Daphne Newell, Jacky Chen, Joshua Arbesman, Pauline Funchain, Lucy Boyce Kennedy

    
  • ·Quick Pemphigus Disease Area Index: A simplified novel scoring system to assess disease severity in the pemphigus group of diseases

    Page :267-269

    Ankan Gupta, Annarani Jose, Mahasampath Gowri S, Dincy Peter, Leni George, Susanne Pulimood

    Plan Plan  
  • ·Efficacy of upadacitinib in patients with severe alopecia areata, including baricitinib-refractory cases: A case series of 22 patients

    Page :269-271

    Fjola Chambres, Florence Tétart, Raphael Janela-Lapert, Hélène Aubert, Fbienne-Nadia Raison-Peyron, Maella Sévérino-Freire, Pascal Joly, Vivien Hébert

    
  • ·Economic and comorbidity burden of prurigo nodularis in the United States between 2017 and 2022: A retrospective matched cohort study

    Page :271-273

    Sarina B. Elmariah, Nicole Princic, Megan Richards, Aamir Qureshi, Lorenzo Sabatelli, Shawn G. Kwatra

     
  • ·Five-year follow-up on randomized controlled trial of fractionated laser resurfacing as prophylaxis against actinic neoplasia

    Page :273-275

    Dan F. Spandau, Ericson Torralba, Christopher Howard, Christina Knisely, Craig A. Rohan, Matthew J. Turner, Jade Bryant, Rita Kamoua, Jeffrey B. Travers

     
  • ·Increased bleeding complications after nasolabial interpolation flap repair with only combined antiplatelet and anticoagulation use: A retrospective, single-center experience

    Page :276-278

    Stephanie Y. Wang, Emily R. Hunter, Karla L. Valdes Morales, Nikhita J. Perry, Eli Feldman, S. Caleb Freeman, Christopher J. Miller, Jeremy R. Etzkorn, Joseph F. Sobanko, Junqian Zhang, Joanna L. Walker, H. William Higgins

    Plan Plan
  • ·Risk factors for regional or distant metastatic disease in sebaceous carcinoma: A retrospective cohort study from the National Cancer Data Base

    Page :278-280

    Nolan J. Maloney, Natasha C. Zacher, Sumaira Z. Aasi, Kelsey E. Hirotsu, Lisa C. Zaba, Nour Kibbi

    
  • ·Ritlecitinib for severe alopecia areata in children under 12 years: A retrospective review of 18 cases

    Page :280-282

    Xue Wang, Yuanxiang Liu, Yujuan Sun, Lin Ma, Zigang Xu, Bin Zhang

    
  • ·Risk of cutaneous T-cell lymphoma in patients with autoimmune diseases

    Page :282-284

    Bethany Brumbaugh, Mike Westmeijer, Beatrix Thompson, Allison Holt, Joseph Ebriani, Kevin Sheng-Kai Ma, Steven T. Chen

    
  • ·Chemosensitization is not associated with improved adjuvant radiation outcomes for cutaneous squamous cell carcinoma: A dual-center retrospective cohort study

    Page :284-287

    Emily E. Granger, Emily Y. Kim, Nina A. Ran, Karina Brito, David M. Wang, Ann W. Silk, Danielle N. Margalit, Roy B. Tishler, Jonathan D. Schoenfeld, Shauna Campbell, Allison Vidimos, Daniel McGrail, Shlomo Koyfman, Emily S. Ruiz

    Plan Plan  
  • ·Diagnostic accuracy of ChatGPT in dermatology: A meta-analysis of textual versus visual prompts

    Page :288-289

    Ryan Chen, Daniel H. Nguyen, Kevin D. Fettel, William J. Nahm, Goranit Sakunchotpanit, Sarah S. Lee, Krithika Nayudu, Vinod E. Nambudiri

     
  • ·Medical triage and screening deficiencies in direct-to-consumer hair loss platforms

    Page :290-291

    Garrett Kraft, Miesha Merati

    Plan Plan
  • ·Oral immune-related adverse events associated with PD-1 and PD-L1 inhibitor therapies: A retrospective, single-institution study

    Page :291-293

    Jasmine H. Wong, Sharen Rivas, Janet Choi, Xin Wang, Lana Salloum, Shaun Wu, Solbie Choi, Shaynie Segal, Rebecca H. Goldberg, Beth N. McLellan

    Plan Plan
  • ·Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX

    Page :293-295

    Brad R. Woodie, Justin A. Freking, Gabrielle M. Rivin, Alan B. Fleischer

    
  • ·Bimekizumab in plaque type psoriasis: Meta-analyses of observational effectiveness studies

    Page :295-298

    Georgios Kokolakis, Isabelle Fovel, Esther Fabre, Kathrin Schlüter, Romy Bley, Luis Möckel, Tobias Möllers

     
  • ·Drug reaction with eosinophilia and systemic symptoms syndrome in association with novel antineoplastic pharmacotherapy: Characterizing reported clinical patterns and outcomes utilizing the Food and Drug Administration Adverse Event Reporting System database

    Page :298-300

    Aryan Mahajan, Priya Agarwal, Gaurav N. Pathak, Babar K. Rao

    
  • ·A decade of scleroderma wound healing: Insights from a specialized wound care center

    Page :301-303

    Natalie Hickerson, Scott A. Elman, Hadar Lev-Tov, Robert S. Kirsner, Jose A. Jaller

     
  • ·Longitudinal cardiovascular outcomes in pyoderma gangrenosum: A propensity-matched TriNetX cohort study

    Page :303-305

    Sach Thakker, Dev Patel, Scott A. Elman

    
  • ·Real-world characteristics of Janus kinase inhibitor-associated acne: A 14-year retrospective cohort study

    Page :306-307

    Peyton V. Warp, Grace Garrett, Rahul Aggarwal, Andrea D. Maderal, Scott A. Elman

    Plan Plan  
  • ·Vulvovaginal involvement in Stevens-Johnson syndrome/toxic epidermal necrolysis: A retrospective review at a tertiary care center (2016-2024)

    Page :307-310

    Beatrix B. Thompson, Natalie M. Baker, Sydney Corey, Bryan Peacker, Natalie Braun, Joseph Ebriani, Mike Westmeijer, Ghida EL Banna, Kevin Sheng-Kai Ma, Mai P. Hoang, Madeline E. DeWane, John C. Trinidad, Michael Stephens, Steven T. Chen

    
  • ·Three-week infliximab dosing is associated with improved disease control in severe hidradenitis suppurativa: A retrospective study

    Page :310-312

    Zahidul Islam, Jasmine H. Wong, Daniel S. Alicea, Solbie Choi, Tyler M. Andriano, Kristina Campton

    
  • ·Efficacy of ruxolitinib cream at different body sites in Chinese patients with nonsegmental vitiligo

    Page :312-314

    Dawei Duan, Caihong Zhu, Jinping Gao, Ruochen Zhang, Xiaojian Chen, He Huang, Zhengwei Zhu, Weiran Li, Tingting Zhu, Hequn Huang, Yang Li, Bo Liang, Yantao Ding, Wenming Zhou, Zhaobing Pan, Yaohua Zhang, Leihong Xiang, Youwen Zhou, Xuejun Zhang, Yan Ding, Bo Zhang

    
  • ·Association between acneiform eruption grade and survival outcomes in EGFRi-treated metastatic colorectal cancer patients: A retrospective cohort study

    Page :314-316

    Michael M. Ong, Stephen W. Dusza, Ryan Sugarman, Rashek Kazi

    
  • ·Oral minoxidil 2.5 mg versus 5 mg for male androgenetic alopecia: A double-blind randomized clinical trial

    Page :316-318

    Larissa Pierri Carvalho Fonseca, Hélio Amante Miot, Christine Rachelle Prescendo Chaves, Paulo Müller Ramos

    
  • ·Quality of life in hospitalized patients with acute generalized exanthematous pustulosis: A prospective qualitative study

    Page :318-321

    Jacob McFeeters, Allison Yan, Cole Veliky, Matthew Gallardo, Kirsten M. Johnson, Kelsey Nusbaum, Rachel M. Kirven, Kristopher Fisher, Abraham M. Korman, Hyoshin Kim, Benjamin H. Kaffenberger

    
  • ·A 48-week real-world outcome of tralokinumab treatment for atopic dermatitis: Systemic therapy-naïve versus systemic therapy-experienced patients

    Page :321-322

    Teppei Hagino, Akihiko Uchiyama, Keiji Kosaka, Takeshi Araki, Hidehisa Saeki, Eita Fujimoto, Sei-ichiro Motegi, Naoko Kanda

     
  • ·Prevalence and demographics of psoriasis in the Down syndrome population: A cross-sectional analysis using the Epic Cosmos dataset

    Page :323-325

    Jillian F. Rork, Jennifer Snide, Dominic S. Strohmeyer, Amy Buros Stein, Kristen E. Holland, Timothy Burdick

    Plan Plan  
  • ·Impact of psychiatric disease and treatment on biologic drug survival in patients with hidradenitis suppurativa

    Page :325-328

    Nikolaj Holgersen, Valdemar Wendelboe Nielsen, Hans-Christian Ring, John R. Ingram, Jacob P. Thyssen, Alexander Egeberg, Simon Francis Thomsen

     
  • ·Investigation of concordance between scalp symptoms, disease severity, and inflammatory activity in scarring alopecias

    Page :328-330

    Carli D. Needle, Anna L. Brinks, Akshay Pulavarty, Caitlin A. Kearney, Carli Tucci, Ambika Nohria, Deesha Desai, Jerry Shapiro, Kristen I. Lo Sicco

    
  • ·Real-world safety of apremilast: A pharmacovigilance analysis using the FDA Adverse Event Reporting System (FAERS)

    Page :330-332

    Zhi-Yuan Chen, Yang Du, Hao Guo

    
  • ·Rural-urban differences in management and survival of sebaceous carcinoma: A National Cancer Database analysis

    Page :333-335

    Rachel C. Chang, Elise K. Brunsgaard, David C. Reid

    Plan Plan  
  • ·Trends in dermatologic biologic prescribing: A Medicare Part D Public Use File analysis from 2018 to 2023

    Page :335-337

    Cathleen V. D'Angelo, Patricia Wilberger, Chase Merritt, Joshua Burshtein, Dawn Merritt

     
  • ·The Standard Dermatology Outcome Measures questionnaire captures improvements in dermatologic disease burden

    Page :337-339

    Ania Stolarczyk, Alice Pentland, Clayton Green, Suephy C. Chen, Julie Ryan Wolf

     
  • ·Health insurance coverage of topical medications in vitiligo and atopic dermatitis

    Page :339-341

    William C. Noel, Asghar Shah, Lionel Bercovitch, Anna Cristina Garza-Mayers

     
  • ·Low-level light therapy as a novel treatment for central centrifugal cicatricial alopecia: An interventional cohort study

    Page :341-342

    Jorge Larrondo, Elizabeth Swain, Victoria Palmer, Ivie Obeime, Brittany Feaster, Katie Lovell, Saroja Rao, Amy McMichael

     
  • ·Upper hair follicle transplantation combined with 308 nm excimer laser for refractory vitiligo: A promising therapeutic approach

    Page :342-345

    Yi Wu, Mengying Duan, Yeqin Dai, Xiuzu Song

    Plan Plan  
  • ·Regional and insurance-based differences in biologic initiation for psoriasis among Medicare and commercially insured individuals in the United States: A Merative Marketscan analysis

    Page :345-347

    Qiwei Wilton Sun, Jeffrey M. Cohen

     
  • ·Efficacy of Phototherapy in Managing Cutaneous Immune-Related Adverse Events in Patients Treated With Checkpoint Inhibitors

    Page :347-349

    Sukul Mittal, Elissa Goorman, Jennifer N. Choi, Cuong V. Nguyen

    
  • ·Epidemiology of sebaceous carcinoma in the United States: Analysis of Surveillance, Epidemiology, and End Results data from 2000 to 2022

    Page :349-351

    Tejas P. Joshi, Jennifer S. Ranario

    
  • ·Use of ritlecitinib in patients with alopecia areata refractory to tofacitinib or baricitinib: A single-center retrospective cohort study

    Page :351-353

    Jundong Huang, Jia Jian, Min Li, Ruxin Ji, Tian Tian, Xiaobing Liang, Zhixiang Zhao, Yan Tang, Fangfen Liu, Ji Li, Wei Shi

    
  • ·Mapping the time course and associated factors of placebo response to systemic immunomodulatory treatments for atopic dermatitis

    Page :353-356

    Huan He, Lu Yu, Boran Yu, Zigang Xu, Peng Guo

    
  • ·Comparing combination and single-agent therapy for the treatment of pemphigus: A retrospective cohort study

    Page :356-358

    Soahum Bagchi, Katherine Brag, Rachel Reardon, Steven T. Chen

    
  • ·The efficacy and tolerability of off-label dupilumab in acantholytic dyskeratotic disorders

    Page :358-361

    Megha Udupa, Bianca Te, Valerie C. Doyon, Touraj Khosravi-Hafshejani

     
  • ·Association between atopic dermatitis and dermatophytosis: A TriNetX retrospective cohort study

    Page :361-363

    Maggie H. Zhou, Jeremy A.W. Gold, Roderick J. Hay, Shari R. Lipner

    Plan Plan
  • ·A pilot study of CO₂ laser-assisted drug delivery of hyaluronidase for the treatment of scleroderma-induced microstomia

    Page :363-365

    Bianca E. Ituarte, Priscilla M. Rosa-Nieves, Makayla Schissel, Ashley Wysong, Sarah L. Lonowski

     
  • ·The P2X7-NLRP3 inflammasome inhibitor AZD9056 has no significant effect on hidradenitis suppurativa clinical disease activity but restores cytokine production in peripheral blood mononuclear cells: Results of a phase 2 trial

    Page :365-368

    James M. Kilgour, Hal Landy, Alexa B. Kimball, Barry I. Resnik, Milan J. Anadkat, Sunil Dhawan, Mark de Souza, Kavita Y. Sarin

     
  • ·Venous thromboembolic risk of combination therapy with intravenous immunoglobulin and Janus kinase inhibitors in dermatomyositis: A retrospective cohort study

    Page :368-369

    Yoo Jung Kim, Joshua Prenner, Kathryn Rentfro, Leila H. Shayegan, Marissa Camillucci, Ruth Ann Vleugels, Neda Shahriari

    

• Health Policy & Practice

  • ·Advocating for insurance coverage of keloids, alopecia, lupus, and sarcoidosis

    Page :370-371

    Henry Zou, Fayven Teklehaimanot, Sarah Seaba, Mohamad Bazzi, Faris Alkhouri, Wyatt Boothby-Shoemaker, Meghan Mansour, Redina Bardhi, Cristian Diaz, Steven Daveluy

     
  • ·Establishing consensus on defining failure of topical therapy in psoriasis: Recommendations from the International Psoriasis Council

    Page :372-375

    Bruce E. Strober, Andrew Blauvelt, Peter C.M. van de Kerkhof, Pravit Asawanonda, Rudi Chandra, Alvaro Gonzalez-Cantero, Cesar Gonzalez, Benjamin Hidalgo Matlock, Julia-Tatjana Maul, Filip Rob, Tiago Torres, Lone Skov

    

• Dermatology Images

  • ·Cutaneous melanoma

    Page :376-384

    Qiao Liu, Hongyu Yang, Yin Yu, Sheng Zhong, Lin Feng

     

• Humanities

  • ·Petrus Gonsalvus and hypertrichosis: How dermatologists help uncover the forgotten histories of marginalized individuals

    Page :385-387

    Alexis Demas

     

• Commentary

  • ·New gene-based classification of ichthyoses and palmoplantar keratodermas: Hereditary epidermal differentiation disorders

    Page :388-389

    Amy S. Paller, Masashi Akiyama, Ángela Hernández-Martín, Juliette Mazereeuw-Hautier, Eli Sprecher, Reclassifying Epidermal Differentiation Disorders Initiative

    
  • ·The enduring impact of the American Dermatological Association on US dermatology

    Page :390-392

    Thomas N. Helm, Amy S. Paller, David M. Pariser

    Plan Plan  
  • ·Older age as an independent risk factor for recurrence in stage II cutaneous melanoma

    Page :393-394

    Gabriella Brancaccio, Elvira Moscarella, Camila Scharf, Giulia Briatico, Eugenia Veronica Di Brizzi, Teresa Troiani, Francesco Iovino, Salvatore Tolone, Renato Franco, Giuseppe Argenziano

     

• Ethics Journal Club

  • ·An ethical framework for managing neglected skin tumors in older patients

    Page :395-396

    Sach Thakker, Kira Minkis, Shari R. Lipner, Nicholas Gulati, Vishal A. Patel, Jafar Al-Mondhiry

    
  • ·Ethical implications of financial incentives with academic funds for research referrals

    Page :397-398

    Timothy Klufas, Ayushya Ajmani, Rishab Sanjeev, Margaret Toro, Albert E. Zhou, Jane M. Grant-Kels

    
  • ·The ethics of financial incentives to improve clinical trial diversity

    Page :399-400

    Alyssa Swearingen, Albert E. Zhou, Jun Lu, Jane M. Grant-Kels

    
  • ·Privilege or equity: Addressing favoritism in dermatology residency admissions: Balancing opportunity, equity, effort, and fairness

    Page :401-402

    Okeroghene Rufin, Shannon Hanggodo, Timothy Klufas, Albert E. Zhou, Jane M. Grant-Kels

    
  • ·Addiction in cosmetic dermatology: An ethical call to action

    Page :403-404

    Sheila Sharifi, Mohammad Jafferany

    
  • ·Ethics of treating actinic keratosis in patients of advanced age

    Page :405-406

    Samer Wahood, Shivani Jain, Megan Hoang, Idowu Olugbade, Nicole A. Negbenebor

    
  • ·Dermatologists' ethical considerations of people experiencing homelessness

    Page :407-408

    Maria J. Etcheverry, Rayva Khanna, Jane M. Grant-Kels

    
  • ·Ethical challenges of issuing workplace accommodation notes

    Page :409-410

    Aarushi K. Parikh, Shari R. Lipner

    
  • ·Ethical considerations in recommending patients avoid cosmetic treatments performed by nonphysician providers

    Page :411-412

    Rachel C. Hill, Jane M. Grant-Kels, Mehdi Farshchian

    
  • ·Preference signaling in dermatology residency: An ethical analysis

    Page :413-414

    Sach Thakker, Thomas Stirrat, Shari R. Lipner, Prince Adotama

    

• Correction

  • ·Correction

    Page :415

    
  • ·Correction

    Page :415

    
  • ·Correction

    Page :415

    

• Beyond JAAD

  • ·Beyond JAAD January 2026

    Page :416-419

    Andrew Bronin

    Plan Plan

• JAAD Online

  • ·Beyond the surface: Ethical approaches to discussing self-harm scars

    Page :e1

    Rahib K. Islam, Aarushi K. Parikh, Edward F. McArdle, Shari R. Lipner

    
  • ·Ethics of ambient documentation

    Page :e3

    Shae Chambers, Ameya Gangal, Benjamin Stoff

    
  • ·Ethical implications of artificial intelligence–written personal statements in dermatology

    Page :e5

    Shannon Hanggodo, Tatyana Koustov, Kelley Sharp, Jane M. Grant-Kels

    
  • ·Navigating the ethics of working with patients who refuse a psychiatry referral

    Page :e7

    Nina Modanlo, Mohammad Jafferany

    
  • ·Ethical implications of rotating or selecting one chief resident

    Page :e9

    Timothy Klufas, Ayushya Ajmani, Rishab Sanjeev, Albert E. Zhou, Hao Feng, Jane M. Grant-Kels

    
  • ·Ethics of professional credential disclosure in advertising

    Page :e11

    Christina Huang, Benjamin K. Stoff, Chase W. Kwon

    
  • ·Ethical implications of double-blinding peer review in academic publishing

    Page :e13

    Ayushya Ajmani, Timothy Klufas, Albert E. Zhou, Brett Sloan, Jane M. Grant-Kels

    
  • ·VYJUVEK for dystrophic epidermolysis bullosa: Ethical dilemmas in access and pricing

    Page :e15

    Rahib K. Islam, Andrew J. Malek, Kazi N. Islam, Rosemary Prejean, Shari R. Lipner, Jashin J. Wu, Christopher J. Haas

    
  • ·Navigating the complexities of pharmaceutical samples and referrals

    Page :e17

    Shannon Hanggodo, Timothy Klufas, Jack Herbster, Albert E. Zhou, Jane M. Grant-Kels

    
  • ·Implications of artificial intelligence scribe usage

    Page :e19

    Timothy Klufas, Shannon Hanggodo, Camilla Lee, Erica Negrini, Albert E. Zhou, Jane M. Grant-Kels

    
  • ·An alternative method for postoperative scalpel blade removal

    Page :e21

    Chase Pitchford, Anuj Kunadia, Landon Hendrickson, Lindsey Collins

    Plan Plan   
  • ·Key issues that need to be addressed to ensure the sustainability of physician-scientist careers

    Page :e23

    Xiaojing Hu, Jiashuai Liu

    
  • ·Response to: Key issues that need to be addressed to ensure the sustainability of physician–scientist careers

    Page :e25

    Albert E. Zhou, Jennifer Chung Chen, Akua Sarfo, Brett Sloan, Jane M. Grant-Kels

    
  • ·Efficacy and safety of 308-nanometer light-emitting diode phototherapy for prurigo nodularis: A randomized and self-controlled clinical trial

    Page :e27

    Lisi Peng, Yixin Shao, Yue Hu, Yanyun Shen, Yiqi Zhu, Wenli Zhang, Shuwen Xu, Duoqin Wang, Hui Tang

    
  • ·Response to Peng et al’s “Efficacy and safety of 308-nanometer light-emitting diode phototherapy for prurigo nodularis: A randomized and self-controlled clinical trial”

    Page :e29

    Gabriela E. Beraja, Ariel E. Eber, Gil Yosipovitch

    
  • ·Comments on “Abrocitinib versus dupilumab: Impact on skin barrier function and proteomics in atopic dermatitis”

    Page :e31

    Yaojun Wang, Zhongcheng Liu

    
  • ·Response to Wang et al., “Comments on ‘Abrocitinib versus dupilumab: Impact on skin barrier function and proteomics in atopic dermatitis’”

    Page :e33

    Jui-Wen Chang, Fang Wang

    
  • ·Enhancing gender-affirming hair loss assessment: Comment on “Scalp hair parameter changes in transgender individuals commencing gender-affirming hormone therapy”

    Page :e35

    Raymond Z. Ezzat, John G. Zampella, Maryanne M. Senna

    
  • ·Response to “Enhancing gender-affirming hair loss assessment: Comment on “Scalp hair parameter changes in transgender individuals commencing gender-affirming hormone therapy””

    Page :e37

    Gia Toan Tang, Rodney Sinclair, Shalem Leemaqz, Ada S. Cheung

    
  • ·Letter to “Enhanced metastatic risk stratification for cutaneous squamous cell carcinoma by combining clinical guidelines with the Erasmus MC model”

    Page :e39

    Youyou Zheng, Shuyue Wei

    
  • ·Response to Zheng et al., “Enhanced metastatic risk stratification for cutaneous squamous cell carcinoma by combining clinical guidelines with the Erasmus MC model”

    Page :e41

    Olivia F.M. Steijlen, Lara Pozza, Joleen J.H. Traets, Barbara Rentroia-Pacheco, Celeste J. Eggermont, Domenico Bellomo, Sheril Alex, Vishal A. Patel, Antien L. Mooyaart, Loes M. Hollestein, Marlies Wakkee

    
  • ·Response to Bissonnette et al “Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control-matched, phase 4 clinical study (BALISTAD)”

    Page :e43

    Julia Clabbers, Celeste Boesjes, Michel van Geel, Marjolein de Bruin-Weller, Antoni Gostynski

    
  • ·Response to: “Response to Bissonnette et al. Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy control–matched, phase 4 clinical study (BALISTAD)”

    Page :e45

    Robert Bissonnette, Elena Goleva, Evgeny Berdyshev, Donald Y.M. Leung

    
  • ·Ultralow-dose rituximab in pemphigus: Weighing clinical benefits against immunologic limitations

    Page :e47

    Ankan Gupta

    
  • ·Response to Gupta et al, “Ultralow-dose rituximab in pemphigus: Clinical efficacy or immunologic underdosing”

    Page :e49

    Shan Cao, Tingting Liu, Wenchao Li, Zhenzhen Wang, Hong Liu, Furen Zhang

     
  • ·Re: “Increased risk of skin cancer in mastocytosis: A large-scale retrospective cohort study of over 20,000 patients”

    Page :e51

    Noor un Nisa Irshad, Pinkey Kumari, Umer Wamiq

    
  • ·Response to Irshad et al, “Re: Increased risk of skin cancer in mastocytosis: A large-scale retrospective cohort study of over 20,000 patients.”

    Page :e53

    Anna Bergström, Mats Lambe, Gunnar Nilsson, Hans Hägglund, Ralf J. Ludwig, Philip Curman

    
  • ·Response to Lauck et al “Cutaneous malignancy after biologic therapy for inflammatory disease: An active comparator, retrospective cohort study”

    Page :e55

    Sheng Li, Cheng Chen

    
  • ·Response to Gooderham et al.’s “Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with chronic hand eczema: results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials.”

    Page :e57

    Nickoulet Babaei, Dahyeon Kim, Mireya Cervantes, Seanna Yang, Minka Gill, Jashin J. Wu

    
  • ·Curbing paper mills in departments and journals

    Page :e59

    Waseem Hassan, Fred Paas

    
  • ·Response to Hassan and Paas, “Curbing paper mills in departments and journals”

    Page :e61

    Albert E. Zhou, Brett Sloan, Dedee F. Murrell, Jane M. Grant-Kels

    
  • ·Remembering Dr Robert Sidbury: Mentor, educator, and servant leader

    Page :e63

    Markus D. Boos, Deepti Gupta, Heather A. Brandling-Bennett

    
  • ·In memoriam for Ronald Leonard Moy M.D.

    Page :e65

    Daniel Mark Siegel

    
  • ·Richard K. Scher, MD

    Page :e67

    Mark Holzberg, Shari R. Lipner, Adam I. Rubin, Phoebe Rich, C. Ralph Daniel

     
  • ·January 2026 iotaderma (#383)

    Page :e69

    Robert I. Rudolph